HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

OSI 930

inhibits both receptor tyrosine kinase Kit and kinase insert domain receptor; structure in first source
Also Known As:
N-(4-trifluoromethoxyphenyl)3-((quinolin-4-ylmethyl)amino)thiophene-2-carboxamide; OSI-930; OSI930
Networked: 8 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Castaldo, Linda: 2 articles (01/2006 - 08/2005)
2. Arkenau, Hendrik-Tobias: 1 article (02/2013)
3. Boinpally, Ramesh: 1 article (02/2013)
4. Brock, Katie: 1 article (02/2013)
5. Camidge, D Ross: 1 article (02/2013)
6. Chick, Jon: 1 article (02/2013)
7. Demetri, George: 1 article (02/2013)
8. Desouza, Nandita M: 1 article (02/2013)
9. Eckhardt, S Gail: 1 article (02/2013)
10. Gedrich, Richard: 1 article (02/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Mast-Cell Leukemia (Leukemia, Mast Cell)
4. Hemorrhage
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
3. Phosphotransferases (Kinase)
4. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
5. Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
6. Tyrosine (L-Tyrosine)
7. Thiophenes
8. Tyrosine Kinase Inhibitors
9. tyrosine receptor (receptor, tyrosine)

Related Therapies and Procedures

1. Therapeutics